Platform · Registry
The cancer dataset that does not exist yet.
Every time the software helps a patient reach the right care, it learns something: what was found, what was decided and what happened next. Over time, that becomes a prospective, outcome-linked registry.
Why it matters
Some of the most important questions have almost no data.
Much of what is known about rare cancers comes from small, retrospective studies at single institutions. Appendiceal cancers and low-grade mucinous tumors are examples, as is the question of where regional therapies such as HIPEC fit best.
A registry that follows patients from the first finding to the outcome, across the health systems they pass through, can help answer them.
Privacy first
Identifiers are removed before anything enters the registry.
Patient information is kept only as long as it is needed to help refer the patient. Identifiers are cleared before a record is admitted to the registry.
The registry and our software are used to improve the software's accuracy over time and, ideally, to improve outcomes for patients.
Keep reading
How it works
Where the registry sits in the loop from finding to decision to outcome.
Detection
Finding the signal that is already in the record.
Navigation
Suggesting the next step, with the clinician deciding.